If an NT scan is positive (increased nuchal translucency), it raises the chance of chromosomal conditions (e.g., Down syndrome), heart defects, or other genetic issues but is not diagnostic. Your clinician will offer follow‑up: noninvasive prenatal testing (cell‑free DNA), diagnostic tests (CVS or amniocentesis), a detailed anatomy/echocardiogram, and genetic counseling. Many babies with raised NT are born healthy.

Best time for a 3D (or 4D) fetal scan is usually between 26 and 32 weeks’ gestation, often optimal around 28–30 weeks. At this stage the baby’s facial features are well developed, there’s still adequate amniotic fluid, and position often allows clear images. Earlier scans show less detail; later scans can be limited by reduced fluid or a cramped fetal position.

Yes — 3D imaging (3D/4D obstetric ultrasound, 3D CT/MRI and dental CBCT) is widely available across India at major hospitals, diagnostic centres and private clinics. Access and cost vary by city and facility; choose an accredited radiology centre and follow your doctor’s advice about indications, timing and safety precautions. Check local prices and whether your insurance covers the scan.

The nuchal translucency (NT) scan, done at about 11–14 weeks, measures fluid at the back of the fetal neck to screen for chromosomal abnormalities and structural problems. It is not intended to determine fetal sex. Occasionally genitalia may be seen then, but accuracy is limited. For reliable sex determination, non‑invasive prenatal testing (NIPT) or the anatomy scan at 18–20 weeks is preferred.

Nuchal translucency (NT) for a male fetus at 11–14 weeks is usually slightly lower than for females, commonly around 1.5–2.0 mm. Values below about 3.5 mm (or below the 95th percentile for crown–rump length) are generally considered normal. Measurements at or above ~3.5 mm are regarded as increased and typically prompt further diagnostic testing.

The nuchal translucency (NT) scan is a routine, non‑invasive ultrasound performed around 11–14 weeks. It uses standard imaging and is considered safe for mother and baby, with no evidence it causes miscarriage or harm. The NT is a screening test for chromosomal or structural risk; abnormal results prompt further diagnostic testing and counselling but do not indicate immediate danger.